UNSPSC 51132100: Combination hematolic drugs

This classification denotes combination drugs that act on blood and blood-forming organs and those that affect the hemostatic system.

UNSPSC 51132100 Combination hematolic drugs is a Class code that nominally addresses pharmaceutical products combining multiple blood-related active ingredients; however, the single recent state and local opportunity tagged under this code shows no relevant activity. Sourcewell, a Minnesota local government cooperative, issued RFP #061626 on May 12, 2026 to establish a master contract for law enforcement equipment — a scope entirely outside the pharmaceutical and hematologic drug domain. The mismatch between the code's intended classification and the actual solicitation indicates that this code does not reflect genuine procurement activity for combination hematolic drugs at the state and local level based on currently available records.

No additional state and local opportunities under UNSPSC 51132100 appear in the recent-opportunities block. The single record present represents a tagging anomaly rather than demand signal for the code's actual commodity. Interested vendors should verify the accuracy of code assignment in any state or local RFP, RFQ, IFB, or ITT notice before committing resources to response, as pharmaceutical procurement codes and law enforcement equipment codes operate under distinct regulatory, compliance, and sourcing frameworks.